All articles tagged with #coreweave
CoreWeave and Anthropic announced a multi-year agreement to run Anthropic’s Claude models on CoreWeave’s AI cloud, enabling production-scale workloads with high performance and reliability; the deal expands CoreWeave’s ecosystem to include nine of the top AI model providers and will begin rolling out later this year.
CoreWeave and Meta Platforms expanded their AI cloud agreement to roughly $21 billion through December 2032, with CoreWeave provisioning dedicated capacity across multiple sites and enabling early NVIDIA Vera Rubin deployments to scale Meta’s AI inference workloads, signaling surging demand for high-performance AI infrastructure.
CoreWeave announced a $21 billion expansion to its AI infrastructure agreement with Meta Platforms, extending cloud capacity through 2032 across multiple locations and including Nvidia Vera Rubin deployments to support Meta’s growing AI workloads; CRWV rose in pre-market trading, and analysts assign a Moderate Buy rating with a target near $115, signaling upside.
CoreWeave (CRWV) is described as a neocloud provider delivering Nvidia GPU-accelerated AI workloads for clients such as Microsoft and OpenAI, backed by a large revenue backlog and rapid scaling toward profitability in the next few years; TipRanks’ technicals currently flag a Buy with a consensus price target around $113.45, implying roughly 38% upside.
Bloom Energy and CoreWeave fell after a Bloomberg report said Oracle and OpenAI scrapped plans to expand a large AI data-center in Abilene, Texas due to financing issues; BE slid about 15% to $135.19 and CRWV about 2.5% to $72.99 as sentiment around AI infrastructure stocks cooled, though Meta and Nvidia were linked to potential alternative arrangements.
Cathie Wood’s ARK Invest purchased about 198,980 CoreWeave shares (~$19.4 million) despite a 19% drop after mixed Q4 results, signaling conviction in AI infrastructure demand. ARK also bought 252,169 shares of Kratos Defense & Security Solutions while trimming exposure to Teradyne and Rocket Lab. Wall Street assigns CRWV a Moderate Buy with a price target around $114, implying ~43% upside; the moves reflect a long‑term AI compute growth thesis rather than near‑term earnings concerns.
CoreWeave (CRWV) posted a mixed Q4 with an 89-cent loss per share on revenue of $1.57B (up 110%), a $66.8B backlog, and guidance below expectations, while pursuing an $8.5B loan backed by a Meta deal. The stock slid over 21% and pulled Nebius (NBIS) and Iren (IREN) lower as profitability remains a sector-wide hurdle for neocloud players; Nebius widened losses to $173M, and Iren returned to a 52-cent-per-share loss. Analysts show Nebius as the only Strong Buy among the group, with Iren offering the biggest upside (over 80%) and CoreWeave about 21% upside but a low Smart Score (3/10). The piece underscores ongoing profitability challenges despite solid AI infrastructure demand.
CoreWeave’s stock fell about 16% after Q4 results showed revenue up 110% to roughly $1.57 billion, but a larger loss and rising debt from rapid data-center expansion spooked investors. The company’s guidance for Q1 revenue of $1.9–2.0 billion and an ~8% operating margin, plus 2026 capex of $30–35 billion, suggest profits may stay thin in the near term despite strong demand and a multi‑billion backlog.
CoreWeave posted a Q4 revenue beat of $1.57 billion and an adjusted loss of 56 cents per share, but its debt ballooned toward $30 billion and interest costs rose, weighing on the stock which fell about 7% after hours as early investor Magnetar continues selling shares.
CoreWeave (CRWV) is set to report Q4 2025 results on Feb 26 amid cautious optimism as data-center demand and AI spending support the business; options traders expect about a 17.11% move on the print. The Street projects a loss of about $0.50 per share on roughly $1.55 billion in revenue. Analysts are mixed but generally positive on long-term catalysts, with Roth Capital and Wells Fargo issuing bullish targets around $110–$125, while TipRanks AI Analyst remains neutral; risks include high debt, customer concentration, and the funding needs for data-center expansion.
Wells Fargo's Michael Turrin reiterates an Overweight rating on CoreWeave (CRWV), arguing that demand for the company's AI compute capacity could lift Q4 FY2025 revenue above the Street estimates. He models about $1.57 billion in Q4 revenue, near the consensus of $1.56 billion, citing over 1 gigawatt of contracted capacity remaining for the next 12–24 months and recent deals with Runway and Poolside; Poolside could represent roughly $1 billion in annual revenue. The stock has jumped about 140% in the last year, and TipRanks shows a Moderate Buy consensus with a target implying roughly 33% upside.
Blue Owl Capital could not arrange debt financing for a $4 billion AI-focused data center in Lancaster, PA co-developed with CoreWeave, with lenders citing CoreWeave’s below-investment-grade credit (B+). Blue Owl has about $500 million in bridge financing due by March 2026; if new debt isn’t secured, the project could face substantial construction costs despite Blue Owl’s assertion that the development is fully funded and on track. The financing hiccup highlights the rising risk in funding hyperscale AI infrastructure.
CoreWeave, an AI-infrastructure provider that surged after its March IPO, faced a late-2025 drop due to debt and AI-spending concerns but has roared higher in 2026 as demand for GPU-backed AI workloads grows; Nvidia invested $2 billion for about 7% of the company and to buy leftover capacity through 2032, backing CoreWeave’s plan to build 5 gigawatts of AI capacity by 2030, with the stock continuing to hinge on ongoing AI spending and leverage risks.
Evercore ISI analyst Amit Daryanani calls Nvidia’s additional $2 billion investment in CoreWeave a game-changing move that could lift Nvidia’s stake to about 12–13% and unlock high-margin software monetization (SUNK and Mission Control) while CoreWeave expands into CPUs and storage, targeting over $100 million in ARR; CRWV carries a rough $126.77 price target with roughly 14–15% upside, though risks include customer concentration and potential GPU obsolescence.
Health-care stocks tumbled after the CMS proposed keeping private Medicare Advantage payments nearly flat for 2027, with UnitedHealth and Humana down about 20%–21% and insurers like CVS/Elevance also lower. Micron rose ~5% on a $24 billion Singapore investment plan. General Motors jumped ~9% after strong earnings and a 20% dividend hike to 18 cents. CoreWeave advanced ~11% on an expanded Nvidia partnership and a $2 billion investment, while Corning rose ~16% on a multiyear Meta data-centers materials deal. Other notable moves included RTX up ~3.7%, Northrop Grumman higher, Boeing down ~1.6%, and airline and steel names among the decliners.